サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451864

血液分析装置および試薬市場レポート：製品タイプ、使用タイプ、価格帯、用途、エンドユーザー、地域別、2024-2032

Hematology Analyzers and Reagents Market Report by Product, Usage Type, Price Range, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 146 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
血液分析装置および試薬市場レポート：製品タイプ、使用タイプ、価格帯、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血液分析装置および試薬の市場規模は2023年に88億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに150億米ドルに達し、2024～2032年の成長率（CAGR）は5.94%になると予測しています。血液疾患の有病率の上昇、高齢者人口の増加、技術の急速な進歩、ポイントオブケア検査（POCT）装置や携帯型血液学分析装置に対する需要の急増、検査室や病院での自動血液学分析装置の採用増加などが市場を牽引する主な要因です。

血液分析装置および試薬は、血液サンプルの正確かつ効率的な評価を可能にし、現代の医療診断において重要な役割を果たしています。様々な血液パラメータを分析し、患者の健康状態に関する貴重な洞察を提供するよう設計されています。血液分析装置は、サンプルハンドリングシステム、流体システム、細胞計数・分化システム、データ処理ユニットなど、いくつかの主要コンポーネントで構成されています。これらの分析装置とともに使用される試薬は、特定の血液成分の検出と測定を容易にします。血液学分析装置には、臨床現場においていくつかの利点があります。迅速な結果が得られるため、タイムリーな診断と治療方針の決定が可能になります。また、高い精度と正確性を備えているため、診断ミスのリスクを最小限に抑えることができます。全血球算定（CBC）、白血球鑑別、ヘモグロビン値など、幅広い血液パラメーターを分析できます。現在、コンパクトな卓上型から大型の全自動システムまで、さまざまなタイプの血液学分析装置が販売されています。

血液分析装置および試薬の市場動向：

血液分析装置および試薬の世界市場は、貧血、白血病、血友病などの血液疾患の有病率の上昇など、いくつかの重要な要因によって加速しています。さらに、老年人口の増加や、血液学分析装置における人工知能（AI）や機械学習（ML）アルゴリズムの統合などの技術の急速な進歩が、市場の成長を促進しています。さらに、迅速で正確な結果を提供する検査室や病院での自動血液学分析装置の採用が増加していることも、市場成長を後押ししています。疾病の早期発見と予防的ヘルスケア対策の重要性に対する意識の高まりや、ポイントオブケア検査（POCT）機器や携帯型血液学分析装置に対する需要の急増も市場成長の要因です。これに伴い、新規試薬や分析装置の開発に重点を置いた血液学の研究開発（R&D）活動への支出が急増しており、市場の成長を後押ししています。さらに、製品ポートフォリオを強化し、地理的プレゼンスを拡大するための主要企業間の戦略的提携や協力関係も、市場成長を後押ししています。

本レポートで扱う主な質問

  • 世界の血液分析装置および試薬市場はこれまでどのように推移してきたのか、また今後数年間はどのように推移するのか？
  • 血液分析装置および試薬の世界市場における市場促進要因、市場抑制要因、市場機会は何か？
  • それぞれの促進要因、抑制要因、機会が血液分析装置および試薬の世界市場に与える影響は？
  • 主要な地域市場は？
  • 最も魅力的な血液分析装置および試薬市場はどの国か？
  • 製品別の市場内訳は？
  • 血液分析装置および試薬市場で最も魅力的な製品は？
  • 使用タイプ別の市場内訳は？
  • 血液分析装置および試薬市場で最も魅力的な使用タイプは？
  • 価格帯別の市場内訳は？
  • 血液分析装置および試薬市場で最も魅力的な価格帯は？
  • 用途別の市場内訳は？
  • 血液分析装置および試薬市場で最も魅力的な用途は？
  • エンドユーザー別の市場内訳は？
  • 血液分析装置および試薬市場で最も魅力的なエンドユーザーは？
  • 世界の血液分析装置および試薬市場の競合構造は？
  • 血液分析装置および試薬の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 血液分析装置および試薬の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 血液学
    • 市場動向
    • 市場予測
  • 止血
    • 市場動向
    • 市場予測
  • 免疫血液学
    • 市場動向
    • 市場予測

第7章 市場内訳：使用タイプ別

  • スタンドアロン
    • 市場動向
    • 市場予測
  • ポイントオブケア
    • 市場動向
    • 市場予測

第8章 市場内訳：価格帯別

  • 低価格
    • 市場動向
    • 市場予測
  • 中価格
    • 市場動向
    • 市場予測
  • 高価格
    • 市場動向
    • 市場予測

第9章 市場内訳：用途別

  • 出血性疾患
    • 市場動向
    • 市場予測
  • 感染症関連疾患
    • 市場動向
    • 市場予測
  • 免疫系関連疾患
    • 市場動向
    • 市場予測
  • 血液がん
    • 市場動向
    • 市場予測
  • 貧血
    • 市場動向
    • 市場予測

第10章 市場内訳：エンドユーザー別

  • 商業サービスプロバイダー
    • 市場動向
    • 市場予測
  • 病院検査機関
    • 市場動向
    • 市場予測
  • 研究・学術機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Bio-Rad Laboratories Inc.
    • Boule Diagnostics
    • Danaher Corporation
    • Diatron MI PLC（Stratec SE）
    • EKF Diagnostics Holdings plc
    • Heska Corporation
    • Horiba Ltd.
    • Mindray Medical International Limited
    • Nihon Kohden Corporation
    • Siemens
    • Sinnowa Medical Science & Technology Co. Ltd.
図表

List of Figures

  • Figure 1: Global: Hematology Analyzers and Reagents Market: Major Drivers and Challenges
  • Figure 2: Global: Hematology Analyzers and Reagents Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Hematology Analyzers and Reagents Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Hematology Analyzers and Reagents Market: Breakup by Usage Type (in %), 2023
  • Figure 6: Global: Hematology Analyzers and Reagents Market: Breakup by Price Range (in %), 2023
  • Figure 7: Global: Hematology Analyzers and Reagents Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Hematology Analyzers and Reagents Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Hematology Analyzers and Reagents Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Hematology Analyzers and Reagents (Haematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Hematology Analyzers and Reagents (Haematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Hematology Analyzers and Reagents (Haemostasis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Hematology Analyzers and Reagents (Haemostasis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Hematology Analyzers and Reagents (Immunohaematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Hematology Analyzers and Reagents (Immunohaematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Hematology Analyzers and Reagents (Standalone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Hematology Analyzers and Reagents (Standalone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Hematology Analyzers and Reagents (Point-of-care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Hematology Analyzers and Reagents (Point-of-care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Hematology Analyzers and Reagents (Low Range) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Hematology Analyzers and Reagents (Low Range) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Hematology Analyzers and Reagents (Mid-Range) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Hematology Analyzers and Reagents (Mid-Range) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Hematology Analyzers and Reagents (High Range) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Hematology Analyzers and Reagents (High Range) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Hematology Analyzers and Reagents (Haemorrhagic Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Hematology Analyzers and Reagents (Haemorrhagic Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Hematology Analyzers and Reagents (Infection-Related Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Hematology Analyzers and Reagents (Infection-Related Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Hematology Analyzers and Reagents (Immune System-Related Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Hematology Analyzers and Reagents (Immune System-Related Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Hematology Analyzers and Reagents (Blood Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Hematology Analyzers and Reagents (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Hematology Analyzers and Reagents (Anaemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Hematology Analyzers and Reagents (Anaemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Hematology Analyzers and Reagents (Commercial Service Providers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Hematology Analyzers and Reagents (Commercial Service Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Hematology Analyzers and Reagents (Hospital Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Hematology Analyzers and Reagents (Hospital Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Hematology Analyzers and Reagents (Research and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Hematology Analyzers and Reagents (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Hematology Analyzers and Reagents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Hematology Analyzers and Reagents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: North America: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: North America: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: United States: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: United States: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Canada: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Canada: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Asia-Pacific: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Asia-Pacific: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: China: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: China: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Japan: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Japan: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: India: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: India: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: South Korea: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: South Korea: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Australia: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Australia: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Indonesia: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Indonesia: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Europe: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Europe: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Germany: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Germany: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: France: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: France: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: United Kingdom: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: United Kingdom: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Italy: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Italy: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Spain: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Spain: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Russia: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Russia: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Latin America: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Latin America: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Brazil: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Brazil: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Mexico: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Mexico: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Middle East and Africa: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Middle East and Africa: Hematology Analyzers and Reagents Market: Breakup by Country (in %), 2023
  • Figure 92: Middle East and Africa: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Global: Hematology Analyzers and Reagents Industry: Drivers, Restraints, and Opportunities
  • Figure 94: Global: Hematology Analyzers and Reagents Industry: Value Chain Analysis
  • Figure 95: Global: Hematology Analyzers and Reagents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hematology Analyzers and Reagents Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Usage Type (in Million US$), 2024-2032
  • Table 4: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Price Range (in Million US$), 2024-2032
  • Table 5: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Hematology Analyzers and Reagents Market: Competitive Structure
  • Table 9: Global: Hematology Analyzers and Reagents Market: Key Players
目次
Product Code: SR112024A8300

The global hematology analyzers and reagents market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.94% during 2024-2032. Rising prevalence of blood disorders, the growing geriatric population, rapid advancements in technology, surging demand for point-of-care testing (POCT) devices and portable hematology analyzers, and the increasing adoption of automated hematology analyzers in laboratories and hospitals are some of the key factors driving the market.

Hematology analyzers and reagents play a crucial role in modern medical diagnostics, enabling the accurate and efficient assessment of blood samples. They are designed to analyze various blood parameters and provide valuable insights into a patient's health. Hematology analyzers consist of several key components, including a sample handling system, a fluidics system, a cell counting and differentiation system, and a data processing unit. Reagents used in conjunction with these analyzers help facilitate the detection and measurement of specific blood components. Hematology analyzers offer several advantages in clinical settings, such as they provide rapid results, allowing for timely diagnosis and treatment decisions. Additionally, they offer high levels of accuracy and precision, minimizing the risk of diagnostic errors. They are capable of analyzing a wide range of blood parameters, including complete blood count (CBC), white blood cell differential, and hemoglobin levels. Currently, there are different types of hematology analyzers available, ranging from compact benchtop models to larger, fully automated systems.

Hematology Analyzers and Reagents Market Trends:

The global hematology analyzers and reagents market is primarily accelerated by several key factors, including the rising prevalence of blood disorders, such as anemia, leukemia, and hemophilia. Moreover, the growing geriatric population and rapid advancements in technology, such as the integration of artificial intelligence (AI) and machine learning (ML) algorithms in hematology analyzers, are driving the market growth. Additionally, the increasing adoption of automated hematology analyzers in laboratories and hospitals, which offer rapid and precise results, is propelling the market growth. The escalating awareness about the importance of early disease detection and preventive healthcare measures and the surging demand for point-of-care testing (POCT) devices and portable hematology analyzers are other factors contributing to the market growth. In line with this, the surging expenditure in research and development (R&D) activities in hematology, focusing on the development of novel reagents and analyzers, is fueling the market growth. Furthermore, strategic collaborations and partnerships among key players to enhance their product portfolios and expand their geographical presence are favoring the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global hematology analyzers and reagents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, usage type, price range, application, and end user.

Product Insights:

Haematology

Haemostasis

Immunohaematology

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the product. This includes haematology, haemostasis, and immunohaematology. According to the report, haematology represented the largest segment.

Usage Type Insights:

Standalone

Point-of-Care

A detailed breakup and analysis of the hematology analyzers and reagents market based on the usage type has also been provided in the report. This includes standalone and point-of-care. According to the report, standalone accounted for the largest market share.

Price Range Insights:

Low Range

Mid-Range

High Range

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the price range. This includes low range, mid-range, and high range. According to the report, low range represented the largest segment.

Application Insights:

Haemorrhagic Conditions

Infection-Related Conditions

Immune System-Related Conditions

Blood Cancer

Anaemia

A detailed breakup and analysis of the hematology analyzers and reagents market based on the application has also been provided in the report. This includes haemorrhagic conditions, infection-related conditions, immune system-related conditions, blood cancer, and anaemia. According to the report, haemorrhagic conditions accounted for the largest market share.

End User Insights:

Commercial Service Providers

Hospital Laboratories

Research and Academic Institutes

Others

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the end user. This includes commercial service providers, hospital laboratories, research and academic institutes, and others. According to the report, commercial service providers represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for hematology analyzers and reagents. Some of the factors driving the North America hematology analyzers and reagents market included the surging demand for personalized medicine and companion diagnostics, the increasing number of clinical trials and drug development activities, and the rising demand for hematology analyzers and reagents in veterinary diagnostics.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global hematology analyzers and reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Bio-Rad Laboratories Inc., Boule Diagnostics, Danaher Corporation, Diatron MI PLC (Stratec SE), EKF Diagnostics Holdings plc, Heska Corporation, Horiba Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Siemens, Sinnowa Medical Science & Technology Co. Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global hematology analyzers and reagents market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global hematology analyzers and reagents market?
  • What is the impact of each driver, restraint, and opportunity on the global hematology analyzers and reagents market?
  • What are the key regional markets?
  • Which countries represent the most attractive hematology analyzers and reagents market?
  • What is the breakup of the market based on product?
  • Which is the most attractive product in the hematology analyzers and reagents market?
  • What is the breakup of the market based on the usage type?
  • Which is the most attractive usage type in the hematology analyzers and reagents market?
  • What is the breakup of the market based on price range?
  • Which is the most attractive price range in the hematology analyzers and reagents market?
  • What is the breakup of the market based on application?
  • Which is the most attractive application in the hematology analyzers and reagents market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the hematology analyzers and reagents market?
  • What is the competitive structure of the global hematology analyzers and reagents market?
  • Who are the key players/companies in the global hematology analyzers and reagents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hematology Analyzers and Reagents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Haematology
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Haemostasis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Immunohaematology
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Usage Type

  • 7.1 Standalone
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Point-of-Care
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Price Range

  • 8.1 Low Range
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Mid-Range
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 High Range
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Haemorrhagic Conditions
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Infection-Related Conditions
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Immune System-Related Conditions
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Blood Cancer
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Anaemia
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Commercial Service Providers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospital Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research and Academic Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Bio-Rad Laboratories Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Boule Diagnostics
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Danaher Corporation
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Diatron MI PLC (Stratec SE)
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 EKF Diagnostics Holdings plc
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Heska Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Horiba Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Mindray Medical International Limited
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Nihon Kohden Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Siemens
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Sinnowa Medical Science & Technology Co. Ltd.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.